JNK2 Is a Positive Regulator of the cJun Transcription FactorAnja Jaeschke, Roger J. Davis, Maria Karasarides et al.|Molecular Cell|2006Cited by 159
First-in-human study of REGN3767 (R3767), a human LAG-3 monoclonal antibody (mAb), ± cemiplimab in patients (pts) with advanced malignancies.Kyriakos P. Papadopoulos, Glenn S. Kroog, Ding Wang et al.|Journal of Clinical Oncology|2019Cited by 38